Glecaprevirpibrentasvir for treating chronic hepatitis C

These evidence-based recommendations on glecaprevir –pibrentasvir (Maviret) for treating chronic hepatitis C in adults were published in January 2018.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news